Department of Paediatrics

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Tembo G. et al, (2026), Vaccine, 75

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Judson MC. et al, (2026), J Neurodev Disord, 18

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.

González-Martínez I. et al, (2026), Am J Hum Genet, 113, 529 - 547

Targeted BDNF upregulation via upstream open reading frame disruption.

Feng N. et al, (2026), Mol Ther, 34, 1652 - 1671

Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.

Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10

Advances in Alphavirus and Flavivirus Research II.

Kim YC. and Reyes-Sandoval A., (2026), Viruses, 18

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Alam N. et al, (2026), EMBO Mol Med, 18, 873 - 890

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235

Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paper.

Turner D. et al, (2026), J Pediatr Gastroenterol Nutr, 82, 867 - 894

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Alam N. et al, (2026), EMBO Mol Med, 18, 873 - 890

Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.

van Beek LF. et al, (2026), J Infect, 92

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Liatsikos K. et al, (2026), Lancet Microbe, 7

Broad lessons from negative trials in rare diseases.

Servais L. and Oskoui M., (2026), Lancet Neurol, 25, 215 - 217

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235

Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway.

Finkel RS. et al, (2026), Expert Rev Neurother, 26, 211 - 225

Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis.

Poleur M. et al, (2026), EClinicalMedicine, 93

Pneumococcal colonisation and mucosal immunity in adults with asthma following experimental human challenge

Reiné J. et al, (2026), BMJ Immunology, 1, e000012 - e000012

MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study

Waldron C-A. et al, (2026), Efficacy and Mechanism Evaluation, 1 - 46

Securing the future of immunisation: ESCMID’s vision

Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167

Search results

Showing results for

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome.

Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.

Targeted BDNF upregulation via upstream open reading frame disruption.

Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.

Advances in Alphavirus and Flavivirus Research II.

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paper.

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.

The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial.

Broad lessons from negative trials in rare diseases.

The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.

Advancing treatment of spinal muscular atrophy through inhibition of the myostatin signaling pathway.

Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosis.

Pneumococcal colonisation and mucosal immunity in adults with asthma following experimental human challenge

MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study

Securing the future of immunisation: ESCMID’s vision

Cookies on this website

Search results

Showing results for